P. W. Wright

发表

Imaging of melanoma with L-131-labeled monoclonal antibodies.

S. Larson, J. Brown, J. Carrasquillo, 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Imaging of melanoma with /sup 131/I-labeled monoclonal antibodies

S. Larson, J. Carrasquillo, Joseph P. Brown, 1983 .

Prognostic factors in patients with resected stage I non‐small cell lung cancer. A report from the Lung Cancer Study Group

M. Gail, R. Ginsberg, C. Mountain, 1984, Cancer.

Immunology and immunotherapy of childhood neoplasia.

I. Bernstein, P. W. Wright, 1976, Pediatric clinics of North America.

Serotherapy of malignant disease.

I. Bernstein, P. W. Wright, 1976, Progress in experimental tumor research.

Serotherapy of malignant disease.

I. Bernstein, K. Hellström, I. Hellström, 1976, The Medical clinics of North America.

Participants in prospective, randomized clinical trials for resected non‐small cell lung cancer have improved survival compared with nonparticipants in such trials

S. Davis, S. Hammar, P. W. Wright, 1985, Cancer.

BLOCKING FACTORS IN TUMOR IMMUNITY AND ALLOGRAFT TOLERANCE

I. Bernstein, K. Hellström, I. Hellström, 1974 .

Tumorigenicity and antigenicity of mouse cells infected with Simian virus 40. I. Relationship of growth in vitro and in vivo in immunosuppressed and immunocompetent recipients.

H. Smith, P. W. Wright, J. McCoy, 1973, Journal of the National Cancer Institute.

Protein antigens of normal and malignant human cells identified by immunoprecipitation with monoclonal antibodies.

J. Brown, I. Hellstrom, K. Hellstrom, 1980, The Journal of biological chemistry.

Early side effects of intrathoracic BCG therapy in patients with stage I squamous cell carcinoma, adenocarcinoma, or large cell lung cancer

M. Gail, C. Mountain, E. Holmes, 1981, Cancer Immunology, Immunotherapy.

Immunological studies in a double blind randomized trial comparing intrapleural BCG against placebo in patients with resected stage I non-small cell lung cancer

M. Gail, W. Heineman, E. Holmes, 2004, Cancer Immunology, Immunotherapy.

Generation of cytotoxic lymphocytes in mixed leukocyte culture by rat lymphoid cells.

I. Bernstein, P. W. Wright, 1976, Transplantation.

Long-term survival in small-cell carcinoma of the lung: a population experience.

D. Scholes, S. Hammar, P. W. Wright, 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Allograft tolerance: presumptive evidence that serum factors from tolerant animals that block lymphocyte-mediated immunity in vitro are soluble antigen-antibody complexes.

I. Bernstein, R. Hargreaves, K. Hellström, 1973, Proceedings of the National Academy of Sciences of the United States of America.

In vitro detection of enhancing antibody by the macrophage migration test.

I. Bernstein, P. W. Wright, 1971, Nature: New biology.

Synergy among rat T cells in the proliferative response to alloantigen.

I. Bernstein, P. W. Wright, S. Loop, 1979, Cellular immunology.

CELL‐MEDIATED REACTIVITY AND SERUM BLOCKING ACTIVITY IN TOLERANT RATS STUDIES ON TEN RATS OPERATIONALLY TOLERANT TO SKIN ALLOGRAFTS USING SEVERAL INDPENDENT ASSAYS

I. Bernstein, K. Hellström, P. W. Wright, 1974, Transplantation.

Induction of immunological tolerance to soluble histocompatibility-2 antigens of mice.

E. Appella, S. Strober, P. W. Wright, 1972, Proceedings of the National Academy of Sciences of the United States of America.

T cell synergy in the rat: serologic characterization of T cell subsets.

I. Bernstein, P. W. Wright, S. Loop, 1980, Journal of immunology.

Quantitative in vitro measurement of simian virus 40 tumor-specific antigens.

P. W. Wright, L. Law, 1971, Proceedings of the National Academy of Sciences of the United States of America.

Preliminary results of combined surgery and adjuvant Bacillus Calmette-Guérin plus levamisole treatment of resectable lung cancer.

A. V. Peterson, I. Bernstein, P. W. Wright, 1978, Cancer treatment reports.

Potentiation of the in vitro specific cytotoxic response to syngeneic lymphoma cells by PPD-stimulated tuberculin sensitive cells.

I. Bernstein, O. Alaba, P. W. Wright, 1979, Cellular immunology.

Generation of cytotoxic lymphocytes in vitro: response of immune rat spleen cells to a syngeneic gross virus-induced lymphoma in mixed lymphocyte-tumor culture.

I. Bernstein, P. W. Wright, E. Cohen, 1976, Journal of immunology.

Imaging of melanoma with L-131-labeled monoclonal antibodies.

S. Larson, J. Carrasquillo, Joseph P. Brown, 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

In vitro relationship of SV40 tumour-specific surface antigen to other SV40 antigens.

P. W. Wright, 1971, Nature: New biology.

Participants in prospective, randomized clinical trials for resected non‐small cell lung cancer have improved survival compared with nonparticipants in such trials

S. Davis, S. Hammar, P. W. Wright, 1985, Cancer.

Activation of RNase L by Murine Coronavirus in Myeloid Cells Is Dependent on Basal Oas Gene Expression and Independent of Virus-Induced Interferon

R. Silverman, Yize Li, S. Weiss, 2016, Journal of Virology.

Activation of RNase L by Murine Coronavirus in Myeloid Cells Is Dependent on Basal Oas Gene Expression and Independent of Virus-Induced Interferon

R. Silverman, Yize Li, S. Weiss, 2016, Journal of Virology.

ABSENCE OF SERUM BLOCKING ACTIVITY IN MICE IMMUNOLOGICALLY TOLERANT TO SOLUBLE HISTOCOMPATIBILITY-2 ANTIGENS

I. Bernstein, E. Appella, P. W. Wright, 1974, Transplantation.

Immunologic enhancement of allogeneic tumor growth with soluble histocompatibility-2 antigens.

E. Appella, S. Strober, P. W. Wright, 1971, Proceedings of the National Academy of Sciences of the United States of America.

Immune response to Gross virus-induced lymphoma: comparison of two in vitro assays of cell-mediated immunity.

R. Herberman, P. W. Wright, M. Ortíz de Landázuri, 1973, Journal of the National Cancer Institute.